Defining the phenotypes for pulmonary hypertension associated with diastolic heart failure

Circulation: Heart Failure

Volumn 4, Issue 3, 2011, Pages 238-240

  Hill, Nicholas S ^a   Preston, Ioana ^a   Roberts, Kari ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

Editorials; heart failure; Hemodynamics; Pulmonary arterial hypertension; Pulmonary vascular disease

Indexed keywords

ARTERIAL OXYGEN SATURATION; COMORBIDITY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIASTOLIC HEART FAILURE; DISEASE ASSOCIATION; HEART FAILURE; HEMODYNAMICS; HUMAN; HYPERTENSION; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; METABOLIC SYNDROME X; MITRAL VALVE DISEASE; OBESITY; PHENOTYPE; PRIORITY JOURNAL; PULMONARY ARTERY OCCLUSION PRESSURE; PULMONARY HYPERTENSION; RECEIVER OPERATING CHARACTERISTIC; REVIEW; SEX DIFFERENCE; SYSTOLIC DYSFUNCTION; FEMALE; MALE; NOTE; PATHOPHYSIOLOGY;

FEMALE; HEART FAILURE, DIASTOLIC; HUMANS; HYPERTENSION, PULMONARY; MALE; PHENOTYPE;

EID: 79960609976     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.111.962217     Document Type: Review

References (25)

1. Thom TJ, Kannel WB. Congestive heart failure: epidemiology and cost of illness. Dis Manage Health Outcomes. 1997;1:75-83. (Pubitemid 127737669)
2. Owan T, Redfield M. Epidemiology of diastolic heart failure. Prog Cardiovasc Dis. 2005;47:320-332. (Pubitemid 40884561)
3. Hogg K, Swedberg K, McMurray J. Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis. J Am Coll Cardiol. 2004;43:317-327. (Pubitemid 38167688)
4. Murali S. Pulmonary hypertension in heart failure patients who are referred for cardiac transplantation. Adv Pulm Hypertens. 2006;5:20-35.
5. Gabby E, Yeow W, Playford D. Pulmonary arterial hypertension is an uncommon cause of pulmonary hypertension in an unselected population: the Armadale Echocardiography Study. Am J Respir Crit Care Med. 2007;175:A713.
6. Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, Elliott CG, Gaine SP, Gladwin MT, Jing ZC, Krowka MJ, Langleben D, Nakanishi N, Souza R. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2009;54(Suppl 1):S43-S54.
7. Burkhoff D, Maurer M, Packer M. Heart failure with a normal ejection fraction: is it really a disorder of diastolic function? Circulation. 2003; 107:656-658. (Pubitemid 36222586)
8. Fowler NO, Noble WJ, Giarratano SJ, Mannix EP. The clinical estimation of pulmonary hypertension accompanying mitral stenosis. Am Heart J. 1955;49:237-249.
9. Moraes DL, Colucci WS, Givertz MM. Secondary pulmonary hypertension in chronic heart failure: the role of the endothelium in pathophysiology and management. Circulation. 2000;102:1718-1723.
10. Shapiro BP, McGoon MD, Redfield MM. Unexplained pulmonary hypertension in elderly patients. Chest. 2007;131:94-100. (Pubitemid 46122979)
11. Robbins IM, Newman JH, Johnson RF, Hemnes AR, Fremont RD, Piana RN, Zhao DX, Byrne DW. Association of the metabolic syndrome with pulmonary venous hypertension. Chest. 2009;136:31-36.
12. Lam CS, Roger VL, Rodeheffer RJ, Borlaug BA, Enders FT, Redfield MM. Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study. J Am Coll Cardiol. 2009;53: 1119-1126.
13. Thenappan T, Shah SJ, Gomberg-Maitland M, Collander B, Vallakati A, Shroff P, Rich S. Clinical characteristics of pulmonary hypertension in patients with heart failure and preserved ejection fraction. Circ Heart Failure. 2011;4:257-265.
14. Tonelli AR, Mubarak KK, Li N, Carrie R, Alnuaimat H. Effect of balloon inflation volume on pulmonary artery occlusion pressure in patients with and without pulmonary hypertension. Chest. 2011;139:115-121.
15. Halpern SD, Taichman DB. Misclassification of pulmonary hypertension due to reliance on pulmonary capillary wedge pressure rather than leftventricular end diastolic pressure. Chest. 2009;136:37-43.
16. Dittrich HC, Chow LC, Nicod PH. Early improvement in left ventricular diastolic function after relief of chronic right ventricular pressure overload. Circulation. 1989;80:823-830. (Pubitemid 19261628)
17. Erickson KW, Costanzo-Nordin MR, O'Sullivan EJ, Johnson MR, Zucker MJ, Pifarré R, Lawless CE, Robinson JA, Scanlon PJ. Influence of preoperative transpulmonary gradient on late mortality after orthotopic heart transplantation. J Heart Transplant. 1990;9:526-537. (Pubitemid 20364446)
18. Vykoukal D, Davies MG. Vascular biology of metabolic syndrome. J Vasc Surg. 2011. [Epub ahead of print].
19. Califf RM, Adams KA, McKenna WJ, Gheorghiade M, Uretsky BF, McNulty SE, Darius H, Schulman K, Zannad F, Handberg-Thurmond E, Harrell FE Jr, Wheeler W, Soler-Soler J, Swedberg K. A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: the Flolan International Randomized Survival Trial (FIRST). Am Heart J. 1997;134:44-54. (Pubitemid 27329022)
20. Packer M, McMurray J, Massie B, Caspi A, Charlon V, Cohen-Solal A, Kiowski W, Kostuk W, Krum H, Levine B, Rizzon P, Soler J, Swedberg K, Anderson S, Demets DL. Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: results of a pilot study. J Card Fail. 2005;11:12-20. (Pubitemid 40215308)
21. Guazzi M, Samaja M, Arena R, Vicenzi M, Guazzi MD. Long-term use of sildenafil in the therapeutic management of heart failure. J Am Coll Cardiol. 2007;50:2136-2144. (Pubitemid 350117342)
22. Lewis GD, Shah R, Shahzad K, Camuso JM, Pappagianopoulos PP, Hung J, Tawakol A, Gerszten RE, Systrom DM, Bloch KD, Semigran MJ. Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension. Circulation. 2007;116:1555-1562. (Pubitemid 47511419)
23. http://clinicaltrials.gov/ct2/show/NCT00763867. Accessed April 4, 2011.
24. Zener JD, Hancock EW, Shumway NE, Harrison DC. Regression of extreme pulmonary hypertension after mitral valve surgery. Am J Cardiol. 1972;30:820-826.
25. Salzberg SP, Lachat ML, von Harbou K, Zünd G, Turina MI. Normalization of high pulmonary vascular resistance with LVAD support in heart transplantation candidates. Eur J Cardiothorac Surg. 2005;27:222-225. (Pubitemid 40193130)